© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Derivatives

Top Section/Ad

Top Section/Ad

Most recent


The Americas derivatives community came together in New York to recognise and celebrate outstanding achievements across the industry
The derivatives market gathered in London on Thursday night to celebrate its leading players
SSA
Internal restrictions mean SSAs issue fewer CMS-linked notes
SSA
JP Morgan and Dutch pension fund PGGM transacted derivatives margin trade
More articles/Ad

More articles/Ad

More articles

  • The Basel Committee on Banking Supervision’s text on non-modellable risk factors is too prescriptive and rigid, and could prevent the appropriate use of data, according to a number of industry associations.
  • Company-wide IT expenditure at ICAP rose by 4% to 16% of revenue in 2014, due in part to the company's SEF build out.
  • Turnover in listed structured products on European exchanges increased in the first quarter of 2014, with trading volume up 25.4% to €33.4 billion, according to the European Structured Investment Products Association.
  • Credit Suisse has launched a one-year double coupon autocall barrier reverse convertible structured product on Tesla Motors, offering investors the opportunity to receive 16% per annum should the underlying on any observation date close at or above the respective payout threshold.
  • European regulators are laying the groundwork for a derivatives market that will lead to greater benefits for non-European banks, according to Kim Taylor, president of CME Clearing. Taylor made the comments at the International Derivatives Expo in London today as EU regulators continue to stall in their authorisation of non-EU clearinghouses.
  • The International Swaps and Derivatives Association has warned that mandatory clearing for over-the-counter equity derivatives could see volumes migrate to the exchange-traded market, diminishing the role for the OTC contracts in risk management.